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“prostate telocytes change 
their phenotype in response 
to castration or testosterone 
replacement”
sérgio Luis Felisbino1, Bruno Domingos Azevedo sanches2, Flávia Karina Delella1, 
Wellerson Rodrigo scarano1, Fernanda Cristina Alcântara Dos santos3, 
patrícia simone Leite Vilamaior4, sebastião Roberto taboga  4 & Luis Antônio Justulin  1
Telocytes are CD34-positive cells with a fusiform cell body and long, thin cytoplasmic projections 
called telopodes. These cells were detected in the stroma of various organs, including the prostate. The 
prostate is a complex gland capable of undergoing involution due to low testosterone levels; and this 
condition can be reversed with testosterone replacement. Telocyte function in the mature prostate 
remains to be dermined, and it is not known whether telocytes can take place in tissue remodeling 
during prostate involution and regrowth. The present study employed structural, ultrastructural and 
immunohistochemical methods to investigate the telocyte’s phenotypes in the ventral prostate (Vp) 
from control (CT), castrated (CS) and testosterone replacement (TR) groups of adult male Wistar rats. 
Telocytes were found in the subepithelial, perimuscular and interstitical regions around glandular 
acini. Telocytes from CT animals have condensed chromatin and long and thin telopodes. In CS group, 
telocytes appeared quiescent and exhibited layers of folded up telopodes. After TR, telocytes presented 
loose chromatin, abundant rough endoplasmic reticulum and enlarged telopodes, closely associated 
with bundles of collagen fibrils. We called these cells “telocytes with a synthetic phenotype”. As 
testosterone levels and glandular morphology returned toward to the CT group parameters, after 10 
days of TR, these telocytes progressively switched to the normal phenotype. Our results demonstrate 
that telocytes exhibit phenotypic plasticity upon androgen manipulation and interact with fibroblast 
and smooth muscle cells to maintain glandular architecture in control animals and during tissue 
remodeling after hormonal manipulation.
A few decades ago, researchers thought the stroma was a static environment that only act to support and nourish 
the epithelia. As such, the cellular milieu would be dominated by fibroblasts that would alternate between a more 
active state, the activated fibroblasts, whose function was restricted to the production of components of the extra-
cellular matrix, and a less active state, the quiescent fibroblasts. However, there is now abundant knowledge that 
fibroblasts comprise a heterogeneous population of cells that may have different origins and functions in stromal 
maintenance1–3, and even quiescent fibroblasts are no longer seen as static cells since they demonstrate high met-
abolic activity4. In addition to fibroblast population heterogeneity in normal tissues, demonstrated mainly in the 
dermis, fibroblasts exhibit great plasticity in pathological conditions, such as cancer-associated fibroblasts5 and as 
part of myofibroblasts6,7. This diversity adds complexity to the study of the stroma. Fibroblast morphology may 
also change in specific contexts such as hypoxia8, a finding that indicates that these cells exhibit a high level of 
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phenotypic plasticity. The same alteration was verified in smooth muscle cells, which exhibit phenotypic plasticity 
with the alternation between contractile and synthetic phenotypes, the latter of which synthesises elements of the 
extracellular matrix during musculature development during certain physiological or pathological contexts9,10. 
Additionally, in pathological conditions, there may be a transition from a contractile to a migratory and phago-
cytic phenotype11.
The stroma complexity has increased with the classification of a new cell type, the telocytes. Telocytes are 
CD34- or CD34- and c-Kit-positive cells that differ morphologically from fibroblasts, pericytes and smooth mus-
cle cells since they have fine and long cytoplasmic extensions called telopodes. These structures are divided into 
dilated sections, podoms (with mitochondria), and fibrillar-like sections, the podomers that display a monili-
form aspect12. Telocytes were detected in the myocardium13,14, skeletal muscle15, jejunum16,17, mammary gland18, 
joints19, sclera20, prostate21,22 and several other organs. The exact function of this cell type remains unclear, 
although there is evidence that telocytes exert organ-specific functions involved in homeostasis, remodelling, 
regeneration, repair, embryogenesis, angiogenesis and others23. The intimate association of telocytes with smooth 
muscle cells has been observed in several organs13,22,24,25. Indeed, it was proposed that telocytes play a supportive 
role in the prostate gland, including smooth muscle cell differentiation and contribution to tissue organisation 
during development26, but the function of telocytes in the mature prostate remains elusive.
Prostate physiology depends on steroid hormones, concentrations of which change throughout life. In some 
species, the prostate gland undergoes drastic seasonal changes27,28. In humans, the prostate responds to increases 
in testosterone (T) concentration, which can lead to pathological conditions such as hyperplasia29,30. Further, T 
deprivation or castration lead to prostate size reduction and hyperplasia reversion28,31. Antiandrogen therapies act 
to reduce the prostatic volume 15 to 25% through apoptosis and glandular epithelial compartment shrinkage32. 
In rodents, castration also reduced prostate volume and increased apoptosis of luminal epithelial cells33, while T 
replacement induced epithelial cell proliferation and restored the secretory epithelium activity34,35. In addition 
to changes in epithelial cells, androgen deprivation promotes smooth muscle cell transition from the contrac-
tile to the synthetic phenotype, without affecting its differentiation status36,37. Telocytes are closely associated 
with smooth muscle in the prostate21,22 and they play an important role in prostate tissue organisation during its 
initial development26, but little is known about telocyte behaviour in the context of androgen deprivation or T 
replacement. Thus, the present study uses histochemical, immunohistochemical and ultrastructural techniques to 
investigate whether telocytes are affected by castration and T replacement in the prostate and whether they play a 
role in prostate gland involution reversal due to T replacement.
Results
Light microscopy. In the CT group, light microscopy indicated possible telocytes or telocytes-like cells 
located in the sub-epithelial region and the perimuscular region of rat VP. These cells had spindle cell bodies, 
reduced cytoplasm and possible long and thin telopodes (Fig. 1a). Twenty-one days after castration, these cells 
presented small telopodes and enlarged cell bodies, while smooth muscle cells appeared with irregular outline or 
with “spinous cell shape” (Fig. 1b). After 3 days of T replacement, smooth muscle cells returned to their regular 
outline, while telocytes-like exhibited abundant cytoplasm and long telopodes located in the subepithelial and 
perimuscular region. Fibroblasts were observed in the interstitial region (Fig. 1c).
Ultrastructural analysis. Telocyte characteristics are best observed using transmission electron micros-
copy. In the VP from CT rats, telocytes were found at three sites: subepithelial, close to the glandular epithelial 
basement membrane; perimuscular, involving the smooth muscle cell layer; and interstitial, distributed in the 
interstitium in close association with thickened collagen fibres and blood vessels. In the CT group, telocytes 
exhibited condensed chromatin and long and thin telopodes (Fig. 2). We verified that telocytes underwent mor-
phological changes upon androgen deprivation. Three days after castration, telopodes were dilated and retracted. 
Smooth muscle cells also underwent morphological changes, including an irregular outline and evident nucleoli, 
findings that indicate a transition from contractile to synthetic phenotype. Further, the prostatic epithelium also 
changed, namely the epithelial basement membrane presented numerous folds (Fig. 3a). Twenty-one days after 
castration, the epithelial basement membrane appeared highly folded and without connections with epithelial 
cells. Perimuscular telocytes have folded telopodes, while subepithelial telocytes show partial or total loss of their 
telopodes. These have also condensed chromatin, which indicates a quiescent or atrophic phenotype (Fig. 3b,c).
There was marked activation of the subepithelial and perimuscular prostatic telocytes in the castrated animals 
after 3 days of testosterone replacement. Specifically, these telocytes demonstrated loose chromatin and a large 
cytoplasm filled with enlarged cisternae of rough endoplasmic reticulum and the Golgi apparatus, changes that 
indicated a synthetic phenotype. Smooth muscle cells, with a distended morphology, appeared at the transition 
from a synthetic to a contractile phenotype (Fig. 4a). Cellular junctions were observed between the telocytes and 
the smooth muscle cells (Fig. 4b) and also between telocytes and epithelial basement membrane and formed 
small spaces that contained thin bundles of collagen fibrils, a result that possibly indicates the secretory activity 
of telocytes (Fig. 4c). Thus, prostatic telocytes were intimately connected with both epithelial and muscle cells 
when both layers were progressively reorganising, a finding that may indicate an organisational role for telocytes 
in glandular regrowth.
After 10 days of TR, the subepithelial and perimuscular prostate telocytes exhibited loose chromatin and 
increased cisternae of rough endoplasmic reticulum and the Golgi apparatus. Subepithelial telocytes also made 
a sequence of several focal adhesions with the epithelial basement membrane and formed small spaces that con-
tained fine bundles of collagen fibrils. Telocyte morphology progressively returned to the normal, non-synthetic 
phenotype, where fusiform cell bodies and less thick telopodes occur (Fig. 5a). Activated fibroblasts are also seen, 
and they have a distinct morphology from normal and synthetic telocyte phenotypes (Fig. 5b).
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Immunohistochemical assays. Telocytes are CD34-positive cells. Thus, CD34 immunohistochemistry was 
performed in the VP to localize these cells. In CT animals, CD34 positive cells were localize in subepithelial region; 
the telopodes were immunolabelled (Fig. 6a). Three and 21 days after castration, CD34 immunostaining was 
observed in the subepithelial region and these cells exhibited abundant cytoplasmic immunostaining, but CD34 
fibrillar-like sections typical of the telopodes are absent (Fig. 6b,c). After 7 days of T replacement, intense CD34 
labelling in the subepithelial region revealed the characteristic pattern of telocytes with CD34 positive fibrillar-like 
sections that are typical of the telopodes (Fig. 6d). The negative control shows no immunostaining (Fig. 6e).
In order to evaluate whether castration and hormone replacement had effects on the presence of AR (andro-
gen receptor) and Ki67 immunoassays were performed in ventral rat prostate of the control rats, 21 days after 
castration and 3 days of T replacement. In the control rats, strong immunolabeling for AR is verified in the 
prostatic epithelium and in stromal cells including some cells with fusiform nucleus in the perialveolar region, in 
which telocytes are normally detected (Fig. 7A). The immunolabeling for Ki67 is verified on dispersed epithelial 
and stromal cells (Fig. 7B). Twenty-one days after castration the immunolabeling for the AR becomes weaker in 
the epithelium, indicating a reduction in testosterone sensitivity and loss of secretory epithelium. AR-positive 
Figure 1. Resin-embedded sections of rat ventral prostates from the three different experimental group of 
animals: control, castrated and castrated plus testosterone (T) replacement. (a) In the control group, possible 
telocytes were observed in the subepithelial and perimuscular regions. These cells had spindle cell bodies 
and a reduced cytoplasm. Fibroblasts were also observed in the interstitial region. (b) Twenty-one days after 
castration, telocytes appeared with reduced or absent telopodes and enlarged cell bodies. Smooth muscle cells 
displayed irregular outline or with “spinous cell shape”. (c) After three days of T replacement, smooth muscle 
cells progressively returned to their contractile phenotype, possible telocytes with abundant cytoplasm, dilated 
nuclei or still incipient telopodes were observed in the subepithelial and perimuscular region, and fibroblasts 
were observed in the interalveolar region. Abbreviations: Ep (epithelium); Tc (telocytes), smc-c (smooth muscle 
cells with contractile phenotype); smc-s (smooth muscle cells with synthetic phenotype); Fb (fibroblasts); M 
(mitosis). Scale bar is 10 μm.
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stromal cells are observed (Fig. 7C). The immunolabeling for Ki67 becomes reduced in both prostatic epithe-
lium and stroma, which indicates a decrease in proliferative activity (Fig. 7D). After 3 days of T replacement, 
the immunolabeling for AR becomes intense again in the prostatic epithelium and AR positive cells are verified 
in the prostatic stroma, including in the perialveolar region (Fig. 7E). Immunolabeling for Ki67 are verified in 
both stromal and prostatic epithelial cells, indicating increased proliferative activity (Fig. 7F). The percentage of 
AR positive cells decreased in both prostatic epithelium and stroma in the group of rats analysed 21 days after 
Figure 2. Ultrastructure of the ventral prostate of control male rats. Telocytes were observed at three sites: 
subepithelial, close to the glandular epithelial basement membrane; perimuscular, involving the smooth muscle 
cell layer; and interstitial, distributed in the interstitium in close association with thickened collagen fibres and 
blood vessels. Telocytes exhibited condensed chromatin and long, flattened cytoplasmic processes (telopodes). 
Abbreviations: Tc (telocytes); Tp (telopodes); Ep (epithelium); Smc (smooth muscle cells); bv (blood vessel). 
Scale bar is 5 μm.
Figure 3. Ventral prostate ultrastructure of animals on day 3 and day 21 after castration. (a) In the castrated 
animal, prostatic telocytes exhibit dilated telopodes, whereas smooth muscle cells already have an irregular 
outline and evident nucleoli, indicating the transition for the synthetic phenotype. (b,c) Twenty-one days after 
castration, subepithelial telocytes present partial or total loss of their telopodes, while the perimuscular telocytes 
exhibit folded telopodes. Smc-s (smooth muscle cells with synthetic phenotype) Tc (Telocyte), Tp (Telopodes); 
Ep (Epithelium); bv (Blood vessel). Scale bar (1 μm).
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castration (CS) compared to the control group (CT), but increased in the group of rats analysed after three days 
of T replacement (TR3) compared to the CS group (Fig. 7H). The percentage of Ki67 positive cells decreased in 
both the epithelium and stroma in the CS group compared to the CT, but increased in the TR3 group compared 
to the other two groups (Fig. 7G).
Immunofluorescence assays. In order to distinguish telocytes from other CD34 positive cells, as endothe-
lial and hematopoietic cells, double immunofluorescence assays for CD34 and CD31, that labels endothelial and 
hematopoietic cells but not the telocytes, were performed. The CD34 positive cells were verified at the periphery 
of the prostatic alveoli in the control group, these cells have long cytoplasmic projections and are CD31 negative, 
which coincides with the profile of the telocytes (Fig. 8A–D). In the group analysed 21 days after castration, 
another pattern of CD34 immunolabeling is observed in the subepithelial region, in this region immunolabelled 
cells with abundant cytoplasm are observed, which diverge from the typical immunolabeling pattern associated 
with the telocytes. These cells also do not present telopodes and the colocalization with CD31 does not occur in 
them. The colocalization of CD34 with CD31 is observed in blood vessels and hematopoietic cells (8e-h). After 3 
days of testosterone replacement, CD34 immunolabeling can be observed in the subepithelial region, with incip-
ient fibrillar-like labeling, which indicates the return of the characteristic pattern of telocytes with the presence 
of telopodes. The colocalization of CD34 and CD31 is observed in blood vessels and hematopoietic cells but not 
in telocytes (8i-l).
serological data. The serum testosterone was 7.1 ± 1.6 ng/mL in CT group. The T levels was below the detec-
tion limit (0.02 ng/mL) in CS21 group (Fig. 9). Testosterone levels were higher in rats TR3 group (13.4 ± 1.8 ng/
mL) compared to TR10 (9.6 ± 1.3 ng/mL). In TR10 group testosterone level is the same observed in the CT (Fig. 9).
Figure 4. Ultrastructure of the ventral prostate of rats 21 days after castration administered 3 days of T 
replacement. (a) T replacement induced a marked activation of perimuscular telocytes, and these cells exhibited 
large cytoplasm filled with enlarged cisternae of the rough endoplasmic reticulum (asterisks). Smooth muscle 
cells appeared at the transition from a synthetic to contractile phenotype with a distended morphology.
(b) Perimuscular telocytes had focal adhesions with smooth muscle cells. (c) Subepithelial telocytes in their 
activated phenotypes have several focal adhesions (arrows) with the epithelial basement membrane and formed 
small spaces (asterisks) that contained fine bundles of collagen fibrils, findings that indicated an intimate 
association between the telocytes and the prostatic epithelium. Abbreviations: Smc (smooth muscle cells); Tc 
(telocytes); Ep (epithelium). Scale bar is 1 μm.
6Scientific RepoRts |          (2019) 9:3761  | https://doi.org/10.1038/s41598-019-40465-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Glandular and cellular changes in epithelium, smooth muscle cells and telocytes due to castration and hor-
mone replacement were presented as a schematic draw in the Fig. 10. Telocytes exhibit remarkable phenotype 
plasticity under androgen handling.
Discussion
Castration has drastic effects on the prostate, leading to gland involution, as reflected in the loss of the secretory 
epithelium and the disorganisation of the supportive prostatic stroma34,35,38. Our data corroborate the effects of cas-
tration on the prostate and add complexity to this process by implicating a new player: telocytes. According to our 
ultrastructural and immunohistochemical results, these cells modify their phenotype after castration. Subepithelial 
telocytes show reduction or loss of their telopodes as well as nuclei dilation. These changes occur simultaneously 
with the progressive loss of focal adhesions with the disorganised secretory epithelium, indicanting a possible 
reciprocal interaction between telocytes and epithelial cells for maintenance the normal cellular phenotype.
Smooth muscle cells in the prostate also establish adherens junctions with telocytes. Junctions between these cells 
were observed in the ileum39 and other organs25. These junctions are lost over the duration of castration, and smooth 
muscle cells undergo drastic changes as demonstrated by the acquisition of a synthetic phenotype marked by an irreg-
ular shape and associations with bundles of collagen fibres. Telocytes may play a broader role in adult prostate tissue 
organisation, not only by compartmentalising the stromal microenvironment26, but by also actively acting on the secre-
tory epithelium and the smooth muscle layer. However, it should be noted that telocytes are also altered reciprocally by 
these other tissue components and prostate function maintenance depends on these multidimensional interactions.
Figure 5. Ultrastructure of the ventral prostate of animals 21 days after castration administered 10 days of T 
replacement. (a) Both subepithelial and perimuscular telocytes exhibited loose chromatin and evident cisternae 
of rough endoplasmic reticulum and the Golgi apparatus (arrowheads). Subepithelial telocytes also have several 
focal adhesions (arrows) with the epithelial basal membrane and formed small spaces (asterisks) that contained 
fine bundles of collagen fibrils (asterisks). Telocyte morphology progressively returned to the normal, non-
synthetic phenotype, in which fusiform cell bodies and less thick and unique telopodes occur. (b) Detail of an 
activated interstitial fibroblast that exhibits loose chromatin and evident cisternae of the rough endoplasmic 
reticulum (arrowheads), and presents a distinct morphology from telocytes with normal or synthetic 
phenotypes. Abbreviation: Tc-s (telocytes with a synthetic phenotype); Tp (telopodes); Ep (epithelium); Smc 
(smooth muscle cells); Tp (telopodes). Scale bar is 1 μm.
7Scientific RepoRts |          (2019) 9:3761  | https://doi.org/10.1038/s41598-019-40465-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Prostate involution reversal was observed by means of T replacement35. Three days after T replacement, telo-
cytes acquired a phenotype similar to the smooth muscle cell synthetic phenotype, with dilated cytoplasm, large 
nuclei and association with bundles of collagen fibrils, and focal adhesions with the epithelium basement mem-
brane and adherens junctions with smooth muscle cells were restored. We term these cells “telocytes with a 
synthetic phenotype”. After 10 days T replacement, the telocytes progressively lost this phenotype and switched 
to the normal phenotype, and simultaneously the prostatic secretory epithelium and the smooth muscle cell layer 
were restored. Serum testosterone levels after 3 days of T replacement were higher than compared to 10 days of 
T replacement, and thus prostatic secretory epithelium restoration depends on the restoration of serum testos-
terone to that observed in the control group. As part of this restoration, the smooth muscle cells returned to the 
contractile phenotype as telocytes progressively reverted to their normal phenotypes. Our immunohistochemical 
data show that telocytes are AR positive and thus sensitive to testosterone, as previously observed by our group26, 
this possibly corroborates the role of this cell type in the reversion of prostate involution induced by castration. 
Previous data indicated that telocytes are also sensitive to estradiol26, and thus prostate telocytes respond to ster-
oid hormones.
In general, our data suggest that telocytes participate in both maintenance and reestablishment of the secre-
tory epithelium and periductal/perialveolar musculature layer of the prostate after T replacement in castrated 
animals.
Conclusion
Our data indicated the presence of telocytes and changes in their morphology during castration-induced prostate 
involution and prostate involution reversal due to T replacement. We observed morphological changes in telo-
cytes during these processes, with the reduction or absence of telopodes and dilated nuclei during castration and 
the acquisition of a phenotype, which we termed synthetic, during the onset of T replacement. Finally, after 10 
days of T replacement, the telocytes began to return to their characteristic phenotype, which occurred along with 
the progressive return of T serum levels to the control group level. Finally, our data demonstrated that prostatic 
telocytes are not static but rather change their phenotypes, and these cells are connected with both the epithelium 
and smooth muscle and are involved in a T-dependent mechanism that is important both in maintaining the 
functionality of the prostate and in reversing its involution.
Material and Methods
Animals. The animals were provided by the São Paulo State University (UNESP, Botucatu). Adult male 
3-months-old Wistar rats were housed in a temperature-controlled (25 °C) room on a 12 h light/dark cycle. All 
of the animals were housed in polyethylene cages, with ad libitum access to filtered water and rodent food. The 
experimental protocol followed the Ethical Principles in Animal Research and the Brazilian legislation established 
by the Brazilian Council of Control in Animal Experimentation and was approved by the Ethics Committee 
for Animal Use from the Institute of Biosciences of Botucatu/UNESP (CEUA protocol 492). The animals were 
divided into three groups: Control rats (CT), untreated castrated rats (CS), and castrated rats treated with testos-
terone replacement (TR).
Castration was performed via orchiectomy at 90 days of age the anesthesy with 100 mL of ketamine 
(0.116 g mL) and 30 mL xylazine (0.02gmL) (1 mL applied per kg body weight). After 21 days of glandular invo-
lution, a group of castrated animals started to receive daily doses of testosterone propionate (4 mg/kg of body 
weight/day) (Sigma-CO) dissolved in corn oil vehicle, subcutaneous injected, for 10 days. CT and CS animals 
received only the vehicle.
Figure 6. CD34 immunohistochemistry in the ventral prostate from control rats, 21 days after castration and 
7 days after T replacement (a) In the control group, CD34 immunolabelling was verified in the subepithelial 
region. The thin cytoplasmic extensions of the telocytes, the telopodes, were CD34 positive. (b,c) Twenty-
one days after castration, another CD34 immunolabelling pattern was observed in the subepithelial region. 
Immunolabelled cells had abundant cytoplasm, which diverged from typical telocyte immunolabelling. These 
cells also did not present telopodes. (c) After 7 days of T replacement, intense CD34 immunolabelling in 
the subepithelial region was observed; this staining follows the characteristic pattern of telocytes with CD34 
positive telopodes. The arrow indicates CD34 immunolabelling.
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Figure 7. AR and Ki67 immunohistochemistry in the rat ventral prostate from CT, CS21 and TR3 groups. (A) 
In the CT group, strong immunolabeling for AR was observed in the prostatic epithelium and in stromal cells, 
including in the perialveolar region, in which telocytes are normally detected. (B) The immunolabeling for Ki67 
is verified on dispersed epithelial and stromal cells. (C) Twenty-one days after castration, the immunolabeling 
for the AR becomes weak in the epithelium, AR-positive stromal cells are observed. (D) The immunolabeling 
for Ki67 becomes reduced in both prostatic epithelium and stroma. (E) After 3 days of T replacement, the 
immunolabeling for AR becomes intense in the prostatic epithelium and AR positive cells are verified in the 
prostatic stroma, including in the perialveolar region. (F) Immunolabeling for Ki67 is verified in both stromal 
and prostatic epithelial cells, indicating increased proliferative activity. (H) The percentage of AR positive cells 
decreased in both prostatic epithelium and stroma in the CS compared to CT group, but increased in TR3 
compared to the CS group. (G) The percentage of Ki67 positive cells decreased in both the epithelium and 
stroma in the CS group compared to the CT, but increased in the TR3 compared to the other two groups. Arrow 
(stromal immunolabeling), arrowhead (epithelial immunolabeling), PA (prostatic alveoli), bar (50 μm).
9Scientific RepoRts |          (2019) 9:3761  | https://doi.org/10.1038/s41598-019-40465-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 8. Double immunofluorescence assays for CD34 and CD31 in the ventral prostate of rats of the control 
group, the group of 21 after castration and the castrated group submitted to 3 days of testosterone replacement. 
(A–D) In the control group, the presence of CD34 immunolabelling in the subepithelial region is verified. The 
thin cytoplasmic extensions of the telocytes, the telopodia, are marked without the occurrence of colocalization 
with the CD31. (E–H) In the group analysed 21 days after castration, another pattern of CD34 immunolabelling 
is observed in the subepithelial region, in this region immunolabelled cells with abundant cytoplasm are 
observed, which diverge from the typical immunolabelling pattern associated with the telocytes. These cells also 
do not present telopodes and the colocalization with CD31 does not occur in them. The colocalization of CD34 
with CD31 is observed in blood vessels and hematopoietic cells. (I–L) After 3 days of testosterone replacement, 
CD34 immunolabeling can be observed in the subepithelial region, with incipient fibrillar-like labeling, which 
indicates the return of the characteristic pattern of telocytes with the presence of telopodes. The colocalization 
of CD34 and CD31 is observed in blood vessels and hematopoietic cells. Arrow (CD34 immunolabeling 
associated with telocytes). PA (Prostatic alveoli), BV (Blood vessels), White bar (100 μm), Yellow bar (50 μm).
Figure 9. Graph of testosterone serum concentration measured for animals of the Control (CT), after 21 days 
of castration (CS), after 3 or 10 days of testosterone replacement (TR3 or TR10, respectivelly). Serum levels of 
testosterone in CS group are below to the detection limit of the test used (0.02 ng/mL). In castrated animals that 
received T replacement, a higher level was observed in the group analysed after 3 days than that analysed after 
10 days of T replacement. The level of serum testosterone of the TR10 group reduces to the CT levels, but the 
value is not statisticaly significant of TR3 group. Different letters mean statisticaly difference with p < 0.05.
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The animals from CS group were euthanised by lethal injection containing a mixture of an anaesthetic, keta-
mine (100 mg/kg bw, Dopalen, Vetbrands, Brazil), and a muscle relaxant, xylazine (11 mg/kg bw, Rompun, Bayer, 
Brazil) after 3 and 21 days of castration, while TR group were killed after 3 and 10 days of the testosterone replace-
ment (8 animals per period of treatment). The ventral prostate (VP) were excised, weighted and immediately 
immersed in fixative.
Hormone assay. Blood samples from each animal were collected at the time of death. The plasma was sep-
arated and stored at −80 °C. Plasma testosterone (T) concentrations were determined by means of automatic 
equipment (VITROS ECi-ECiQ analyzer, Johnson & Johnson Inc., New Brunswick, NJ, USA) using specific rea-
gents supplied by Johnson & Johnson Ortho-Clinical (Johnson & Johnson OrthoclinicalTM, New Brunswick, NJ, 
USA). The sensitivity of this assay was 0.02 ng/mL. The intra-assay and inter-assay variations for the T assay were 
5.36% and 5.10%.
Figure 10. Schematic draw that depicts the modifications to the epithelium, smooth muscle cells and telocytes 
due to castration and testosterone replacement. In the control group, the telocytes, smooth muscle cells and 
secretory epithelium exhibit their characteristic morphology. After castration, luminal epithelial cells undergo 
apoptosis, prostatic epithelium is dominated by basal cells, and subepithelial telocytes exhibit either partial or 
total loss of telopodes, while perimuscular telocytes show folded telopodes and smooth muscle cells switch to 
the synthetic phenotype. As testosterone replacement occurs, the secretory epithelium develops again, telocytes 
exhibit a synthetic phenotype, with both dilated nuclei and cytoplasm and the loss of their telopodes and 
smooth muscle cells progressively return to their contractile phenotype. Finally, after 10 days of testosterone 
replacement, as serum testosterone levels return to that seen in the control group, the prostatic secretory 
epithelium can be observed, smooth muscle cells are in their contractile phenotype and form a thin layer 
surrounded by telocytes, these progressively return to their characteristic phenotype, with telopodes and a 
fusiform cell body.
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Immunohistochemistry. Immunohistochemical assays of paraffin-embedded tissues sections were per-
formed using the protocol described in Justulin et al.33. Ventral prostates were fixed in 4% paraformaldehyde 
dissolved in phosphate buffer saline for 24 hours. Fixed samples were dehydrated in graded ethanol series, clar-
ified in xylene and embedded in Paraplast (Sigma-CO). Five-µm prostate sections were cut and mounted on 
silanized slides. Prior to staining, the sections were dewaxed, rehydrated and then unmasked in 0.01 M citrate 
buffer (pH 6.0). The anti-CD34 (mouse polyclonal, sc74499, Santa Cruz Biotechnology), anti-Ki67 (rabbit mono-
clonal, ab16667, Abcam), anti-androgen receptor (rabbit polyclonal, sc816, Santa Cruz Biotechnology) antibodies 
were applied to the sections and incubated overnight at 4 °C. A secondary antibody complexed with peroxi-
dase was utilized and the detection with 3,3′-diaminobenzidine as substrate was done. Counterstaining was per-
formed with Harris hematoxylin. Analyzes were carried out using a DMLB Leica Microscope and the images were 
obtained by a Leica DFC300FX digital camera connected to the microscope.
Immunofluorescence assays. Immunofluorescences of paraffin-embedded tissues sections were per-
formed using the protocol described in in Sanches et al.26. The prostate glands of rats of the control group, the 
group of 21 after castration and the castrated group submitted to 3 days of testosterone replacement were fixed 
by immersion in 4% paraformaldehyde (buffered in 0.1 M phosphate, pH 7.4) for 24 h. After fixation, the tissues 
were washed in water, dehydrated in ethanol series, paraffin embedded (Histosec, Merck, Darmstadt, Germany) 
and sectioned at 5 μm on a Leica microtome (Leica RM2155, Nussloch, Germany). Such sections of prostate 
gland were subjected to immunofluorescence assays to evaluate the presence of telocytes throughout the cas-
tration induced tissue remodelling and to distinguish these cells from other CD34 positive cells. Therefore, 
double-immunofluorescence assays for CD34 (mouse polyclonal, IgG, B-6, sc74499, Santa Cruz Biotechnology, 
Dallas, TX, USA) and CD31(rabbit polyclonal, ab28364, Abcam, Cambridge, MA, USA), a marker of endothelial 
and hematopoietic cells, were performed; these antibodies were incubated at a dilution of 1:100 overnight. On 
the following morning, the sections were incubated with goat anti-mouse antibody (FITC, sc-2011, Santa Cruz 
Biotechnology, Dallas, TX, USA) and goat anti-rabbit (Texas Red, sc-2780, Santa Cruz Biotechnology, Dallas, TX, 
USA) secondary antibodies diluted 1:200 in 1% BSA for 2 h at room temperature and then stained with DAPI 
(F36924, Life Technology, Grand Island, NY, USA). Histological sections were analysed with a ZeissImager M2 
fluorescence microscope (Zeiss, Germany) coupled with AxioVision software (Zeiss, Germany).
transmission electron microscopy (teM). Fragments of VP from different experimental groups were 
processed for TEM. Tissue fragments (1 mm3) were fixed with 3% glutaraldehyde plus 0.25% tannic acid in 
Millonig’s buffer containing 0.54% glucose26. Tannic acid was chosen for better preservation and visualization of 
the fibrilar components. After washing with the same buffer, the material was post-fixed with 1% osmium tetrox-
ide, washed again, dehydrated in graded acetone, and embedded in Epon 812. Ultrathin silver sections were cut 
using a diamond knife on a LKB ultramicrotome and contrasted with alcoholic uranyl acetate and lead citrate. 
Grids were examined in a Phillips CM 100 transmission electron microscope operating at 80 kV.
statistical analysis. The values are expressed as mean ± SD. One-way analysis of variance was performed to 
determine whether differences existed among all groups and then the Tukey Kramer post-test was employed to 
determine the significance of the differences. A p-value of < 0.05 was considered significant. Statistical analyses 
were performed using Instat version 3.0 software (GraphPad, San Diego, CA, USA).
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